Stefan Proniuk serves as Executive at Arno Therapeutics, Inc, where they oversee executive responsibilities. Since joining the company, Stefan Proniuk has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 29, 2013 involved receiving (via award) 666 shares valued at $1.6K.
Stefan Proniuk currently holds 10,047 shares of Arno Therapeutics, Inc (ARNI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stefan Proniuk has been a net neutral trader of ARNI stock. They have purchased $0 and sold $0 worth of shares.
Stefan Proniuk's most recent insider trade was on Oct 29, 2013, when they sold 666 shares at $2.40 per share.
Get notified when new Form 4 filings are submitted
| $2.40 |
| Discretionary |
| May 28, 2013 | ARNI | $387 | Other | 1,289 | $0.30 | Discretionary |
| Apr 29, 2013 | ARNI | $400 | Other | 1,333 | $0.30 | Discretionary |
| Mar 27, 2013 | ARNI | $400 | Other | 1,333 | $0.30 | Discretionary |